The authors of an editorial published online February 7 in the Journal of Nuclear Cardiology pose the opinion that it might be time to pump the brakes on wider use of PET/MRI, at least in cases of cardiac sarcoidosis.  “The true generalizability of hybrid PET/MRI for cardiac sarcoidosis, therefore, remains in question,” they added. “Although the potential benefits are undeniable, the practical value in patients with suspected or confirmed cardiac sarcoidosis is yet to be determined.” {Read More Here}